ERCP-related bleeding in the era of multiple antiplatelet agents
-
- STATUS
- Not Recruiting
Summary
The purpose of this study is to determine the true incidence of ERCP-related bleeding among those patients who are taking anti-platelet agents, especially in the era of multiple agents, and to compare the incidence of ERCP-related bleeding among patients who are taking no anti-platelet agents versus aspirin versus a single anti-platelet agents other than aspirin versus multiple anti-platelet agents.
Description
The purpose of this study is to determine the true incidence of ERCP-related bleeding among those patients who are taking anti-platelet agents, especially in the era of multiple agents, and to compare the incidence of ERCP-related bleeding among patients who are taking no anti-platelet agents versus aspirin versus a single anti-platelet agents other than aspirin versus multiple anti-platelet agents.
Details
| Condition | ERCP |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX6359 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.